Annual Symposium on Nonhuman Primates

非人类灵长类动物年度研讨会

• 批准号: 10676977
• 负责人: R. PAUL JOHNSON
• 金额: $ 7.5万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-08-15 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10676977
• 关键词: AIDS Vaccines; Acceleration; Acquired Immunodeficiency Syndrome; Address; Adult; Antibodies; Applications Grants; Budgets; COVID-19 pandemic; COVID-19 pathogenesis; COVID-19 treatment; COVID-19 vaccine; California; Child; Clinic; Clinical; Collaborations; Communicable Diseases; Development; Disease; Emerging Technologies; Fees; Fostering; Funding; Future; Generations; Genomics; Grant; HIV; HIV Infections; HIV Vaccine Trials Network; HIV vaccine; HIV/AIDS; Health; Human; Hybrids; Immunologic Deficiency Syndromes; Immunology; Individual; International; Intervention; Journals; Knowledge; Life; Link; Logistics; Medical; Mentors; Mission; Modeling; NIH Vaccine Research Center; Oral; Oregon; Participant; Pathogenesis; Pennsylvania; Persons; Prevention; Preventive vaccine; Primates; Publishing; Research; Research Personnel; Role; Rotation; SIV; Scientific Advances and Accomplishments; Scientist; Technology; Testing; Translations; United States National Institutes of Health; Vaccines; Virus Diseases; Writing; antiretroviral therapy; co-infection; coronavirus disease; cost; disability; experience; falls; global health; meetings; neutralizing antibody; nonhuman primate; novel therapeutics; originality; posters; prevent; programs; response; symposium; therapy design; transmission process

PROJECT SUMMARY With this R13 application, we request funding to support, in part, the costs for planning, publicizing, and hosting the 39th, 40th, and 41st Annual Symposia on Nonhuman Primate Models for AIDS. For four decades, this symposium has served as the premier scientific forum for the exchange of information, including new research findings and scientific perspectives, among HIV/AIDS investigators whose research includes studies in nonhuman primates (NHPs). Disseminating the latest research findings in NHP models of AIDS while also facilitating discussion and exchange of information between basic scientists and clinicians remains a priority, as do focusing on emerging technologies to accelerate translation of NHP studies into the clinic and engaging a broader and more diverse group of researchers in HIV/AIDS research in NHP models. This meeting, the only one of its kind in the world, convenes an international group of scientists whose research focuses on the study of natural and experimental immunodeficiency virus infections in NHPs, as well as on the development of novel therapeutics, prophylactic vaccines for HIV, and curative approaches. Emerging topics in related infectious diseases (such as COVID-19 pathogenesis, vaccines and treatment) may also be included. The seven National Primate Research Centers (NPRCs) host this meeting in rotation, and upcoming symposia hosts will be the Yerkes (2022), California (2023), and Tulane (2024) NPRCs. We plan a hybrid format with most participants attending in person and others joining online to access oral and poster sessions. The conference will begin on day 1 with registration, a keynote address by a leading HIV/AIDS researcher, and an evening reception. The following two and a half days will include scientific presentations from invited speakers and accepted oral abstracts. Each symposium scientific committee will select session topics and speakers to highlight new and cutting-edge technologies in their respective fields. Each session will open with a 30-minute talk by an invited chair. Individuals whose abstracts are accepted for oral presentations will give the remaining session talks. A poster session will occur on the evening of day 2, and there will be a banquet on the evening of day 3. As is traditional for this symposium, the Journal of Medical Primatology will publish all poster and oral abstracts in a special issue. In partnership with the HIV Vaccine Trials Network (HVTN), the NHP AIDS Symposium will also host a pre-symposium meeting for early stage investigators (ESI). This meeting will be open to the attendees of a linked ESI Conference the HVTN sponsors. ESI attendees and mentors will focus on grant writing, budgeting, and networking, and will participate in a Q&A with NIH Program Officers. We believe bringing together researchers from a variety of diverse backgrounds will generate future collaborations and scientific advances. Knowledge shared and gained at upcoming Annual Nonhuman Primate Models for AIDS Symposia will further the continued, effective use of NHP models to maintain long term control of HIV replication in the absence of antiretroviral therapy and to design interventions to prevent or eradicate HIV infection.

项目总结 对于这个R13应用程序，我们请求资金来部分支持规划、宣传和托管的成本 第39届、第40届和第41届艾滋病非人类灵长类动物模型年度研讨会。四十年来，这 研讨会已成为包括新研究在内的信息交流的首要科学论坛 艾滋病毒/艾滋病调查人员的研究结果和科学观点，其研究包括 非人灵长类(NHP)。在艾滋病的NHP模型中传播最新研究成果，同时还 促进基础科学家和临床医生之间的讨论和信息交换仍然是优先事项， 将重点放在新兴技术上，以加快将NHP研究转化为临床并参与 在NHP模式下进行艾滋病毒/艾滋病研究的更广泛和更多样化的研究人员群体。这次会议，唯一的 世界上同类研究之一，召集了一个国际科学家小组，他们的研究重点是这项研究 自然和实验性免疫缺陷病毒在NHP中的感染情况，以及新的 治疗学、艾滋病毒预防性疫苗和治疗方法。与传染病相关的新课题 疾病(如新冠肺炎的发病机制、疫苗和治疗)也可能包括在内。七个国家 灵长类研究中心(NPR)轮流主办这次会议，即将举行的研讨会主持人将是 耶克斯(2022年)，加利福尼亚州(2023年)和杜兰(2024年)全国人民代表大会。我们计划与大多数参与者一起采用混合模式 亲自出席，其他人加入在线访问口头和海报会议。会议将于#时开始。 注册的第一天，一位领先的艾滋病毒/艾滋病研究人员的主旨演讲，以及晚上的招待会。这个 接下来的两天半将包括受邀演讲者的科学演讲和被接受的口头演讲 摘要。每个研讨会科学委员会将选择会议主题和演讲者，以突出新的和 各自领域的尖端技术。每节课将以一位受邀嘉宾30分钟的演讲开始。 椅子。其摘要被接受为口头报告的个人将在剩余的课程中进行演讲。一个 招贴会将在第二天晚上举行，第三天晚上将举行宴会。 对于这次研讨会，传统的医学灵长类动物学杂志将在一个 特刊。与艾滋病毒疫苗试验网络(HVTN)合作，国家卫生计划艾滋病研讨会还将 为早期调查人员(ESI)主持一次研讨会前会议。此会议将向与会者开放 由HVTN赞助的关联的ESI会议。ESI的与会者和导师将专注于拨款的撰写， 预算和网络，并将参加与NIH项目官员的问答活动。我们相信带着 来自不同背景的研究人员将共同创造未来的合作和科学 预付款。在即将举行的艾滋病年度非人灵长类动物模型研讨会上分享和获得的知识 将进一步继续有效地使用国家卫生计划模式，以保持对艾滋病毒复制的长期控制 缺乏抗逆转录病毒治疗，并设计预防或根除艾滋病毒感染的干预措施。